Donate to CCA’s 2021 End of Financial Year Appeal

Want to have an impact on generations to come? Invest in Crohn’s and Colitis Australia’s research programs and projects. Your donation could be the catalyst for the next discovery in inflammatory bowel disease research.

My name is Paul Pavli and I am a gastroenterologist at Canberra Hospital and a Professor of Medicine at the Australian National University Medical School.

I have been a supporter of Crohn’s and Colitis Australia (CCA) since it was established in 1985, when it was called the Australian Crohn’s and Colitis Association.  I remember well the vision of its founder, Angela McAvoy AM, and her colleagues – one of their main aims was to foster research into Crohn’s disease and ulcerative colitis.

I have always been interested in research and, after training as a gastroenterologist, I moved to Canberra to do a PhD in the basic sciences of the gut immune system.  My patient focus was inflammatory bowel disease (IBD), which was quite rare at the time. As I developed my knowledge and skills, I became curious about the relationship between genetics and Crohn’s and colitis. This is what began my own journey into researching the genes that are connected with the development of IBD.

“In the world of IBD research, getting funding to develop a dietary treatment can be really difficult. Hence, as a scholarship recipient of CCA, this funding has enabled research from my team to gain important insights in how diet affects gut symptoms (and function) in ulcerative colitis and in pouchitis.”
Dr Chu Kion (CK) Yao,
Angela McAvoy Research Scholarship recipient

CCA provided the initial funds and helped recruit families around Australia to study the genetic causes of IBD. As the research progressed, we reached a stage where our research group was successful in obtaining government funding and making important contributions to the International IBD Consortium, which in turn made further discoveries about the genes that cause IBD. These discoveries led to more questions about the environment, diet and the microbiome, and we continue to grow our understanding about the complex interplay between genes and Crohn’s and colitis.

From little things, big things grow!

“I am grateful to the CCA for supporting my research into novel therapies for inflammatory bowel disease. As a scholarship recipient, I have been able to conduct studies into a novel anti-inflammatory cytokine, and cell-based therapies for IBD.”
– Dr Rimma Goldberg,
Fenton Family IBD Research Scholarship

CCA has a record of supporting research, both clinical and basic science.  For example, the development of IBD Standards of Care and the CCA IBD Quality of Care Audit provided information that has enabled many hospitals to improve the delivery of care to Crohn’s and colitis patients. This was made possible through the generosity of people like you.

By consulting the Crohn’s and colitis community and healthcare workers, CCA will identify those research areas that are of greatest importance to them. With that information CCA will seek support from government, industry and you to drive research into answering the most asked questions. CCA wants to continue to work with the Crohn’s and colitis community to unravel the complexity of IBD via the CCA Research Priorities Project, which will narrow down the top Crohn’s and colitis research questions.

Over the past 9 years, the Crohn’s and colitis community has been incredibly generous, contributing over half a million dollars to CCA’s IBD research scholarships. By donating, you can support emerging researchers in this field who often lack the funding to get started.

To donate, please complete the attached form and return it in the enclosed reply paid envelope, or donate online at any time and a tax deductible receipt will be emailed to you. If you prefer, you can call CCA on 1800 138 029 to make a donation or for more information on regular giving to support CCA and the Crohn’s and colitis community.

Thank you for considering a gift of any size and helping to advance research into Crohn’s and colitis.

Yours sincerely,

Professor Paul Pavli AM